Watch CBS News

FDA panel considers Pfizer vaccine for kids

An FDA advisory panel is meeting today to consider if millions of younger children, ages 5 to 11, should be eligible for Pfizer's COVID-19 vaccine. CBS News' Laura Podesta joins CBSN AM with the latest.
Oct 26, 2021 (04:16)
View CBS News In
CBS News App Open
Chrome Safari Continue